, Singapore

SIA places new cabin products in London and Hong Kong flights

The new cabin products seat up to 471 customers in four classes.

Singapore Airlines (SIA) assigned its newest Airbus A380 aircraft and its cabin products to its London and Hong Kong flights.

According to a press release, starting 16 February 2018, the aircraft will operate to London as SQ322. From 17 February 2018 to 5 April 2018, it will operate as SQ305.

On 7 April 2018, the new aircraft are scheduled to operate as SQ317.

Meanwhile, from 18 February 2018 to 6 April 2018, the new A380s will also be deployed on services to Hong Kong as SQ860 and SQ863.

With effect from 8 April 2018, the aircraft are scheduled to as SQ856 and SQ861.

The new cabin products will initially be fitted to the five new A380s, following which retrofit work will commence on 14 aircraft that are already in service.

The new cabin products seat up to 471 customers in four classes, with six in Suites, 78 in Business Class, 44 in Premium Economy Class and 343 in Economy Class.  

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare